CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most ...

Cresco Labs reported in-line financial results last August and restructured its debt. Click here to read an analysis of CRLBF ...

CHICAGO--(BUSINESS WIRE)--Cresco Labs (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “the Company”), a vertically integrated, multi-state operator and the cannabis industry’s No. 1 producer of branded ...

Cresco Labs Inc. reported an ugly Q1 2023 with revenues falling 10% YoY. This MSO is likely to languish due to the Columbia Care merger struggling to complete divestitures needed for regulatory ...

Cresco Labs Inc. (OTCMKTS:CRLBF – Free Report) – Stock analysts at Alliance Global Partners dropped their FY2025 EPS estimates for shares of Cresco Labs in a note issued to investors on Wednesday, ...

The state of Ohio has started issuing operational licenses for dual-use cannabis cultivators, bringing the state one step closer to recreational marijuana sales.One of the first businesses to get that ...

WAWARSING, N.Y. — At its groundbreaking ceremony last year, cannabis wholesaler Cresco Labs promised to create 75 jobs by the spring of 2023 but has yet to meet that goal. “The facility is not ...

During the last three years, shares of Cresco Labs (OTC: CRLBF) lost 76% of their value. Shareholders are doubtlessly hoping that the next three years will be a lot better. Is that a realistic hope?

Revenue for Chicago-based Cresco Labs (CSE: CL) (OTC: CRLBF) fell 9% in the second quarter ended June 30, compared with the same period a year ago. But the $198 million brought in during the period ...

At the Benzinga Cannabis Capital Conference in Florida, Cresco Labs' CRLBF CEO Charlie Bachtell shared optimistic views on cannabis rescheduling, emphasizing the importance of the process it's ...

In its second quarter, Cresco booked revenue of $198 million. This was up on a sequential basis, if only marginally (by 2%), and down by 9% on a year-over-year comparison. The net loss landed just shy ...

Cresco Labs Q4 revenue is $175.91M, surpassing estimates of $172.13M. Adjusted EBITDA hit $42M with a 24% margin. Gross margin drops to 47.8% from 51.1%, while operating profit declines to $19.41M.